US Stock MarketDetailed Quotes
CDIO Cardio Diagnostics
- 0.247
- +0.003+1.31%
Close Nov 21 16:00 ET
10.00MMarket Cap-824P/E (TTM)
0.267High0.230Low1.08MVolume0.240Open0.244Pre Close263.16KTurnover2.96%Turnover RatioLossP/E (Static)40.44MShares3.56052wk High2.72P/B9.01MFloat Cap0.19052wk Low--Dividend TTM36.42MShs Float10.250Historical High--Div YieldTTM15.11%Amplitude0.171Historical Low0.244Avg Price1Lot Size
Cardio Diagnostics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -10.79%-1.16M | 6.38%-1.21M | 25.23%-1.23M | -11.42%-5.67M | 45.98%-1.69M | 24.84%-1.04M | -227.49%-1.29M | -786.17%-1.65M | -769.82%-5.09M | -3.12M |
| Net income from continuing operations | 26.90%-1.41M | 67.98%-1.29M | -303.21%-4.16M | -79.72%-8.38M | 41.59%-1.39M | -67.91%-1.93M | -377.78%-4.02M | -256.01%-1.03M | -651.23%-4.66M | ---2.38M |
| Operating gains losses | ---- | ---- | ---- | ---5.6M | ---248.87K | ---81.91K | --418.11K | ---5.69M | ---- | ---- |
| Depreciation and amortization | 105.14%82.52K | 1,592.45%81.12K | 492.20%28.34K | 597.63%111.62K | 1,445.43%61.82K | 905.63%40.23K | 19.83%4.79K | 19.63%4.79K | 0.00%16K | --4K |
| Other non cash items | ---- | ---- | ---- | 5,857.77%6.7M | --92.22K | --561.51K | 1,795.27%1.04M | 8,609.11%5.01M | 3,531.96%112.53K | --0 |
| Change In working capital | -49.29%150.07K | -124.63%-30.26K | 609.84%382.79K | 137.39%208.81K | 64.63%-263.92K | 221.81%295.96K | -68.35%122.85K | 26.99%53.93K | -1,386.84%-558.52K | ---746.21K |
| -Change in receivables | -1,040.00%-6.58K | 1,192.19%11.47K | ---14.03K | -650.50%-4.96K | ---4.61K | --700 | ---1.05K | --0 | 200.00%901 | --0 |
| -Change in prepaid assets | -39.94%190.41K | -13.42%186.26K | 39.89%470.05K | 207.90%750.77K | 81.97%-117.4K | 973.98%317.04K | 327.89%215.12K | 1,550.48%336.01K | -2,143.77%-695.77K | ---651.25K |
| -Change in payables and accrued expense | 180.19%22.73K | -89.25%-172.64K | 93.44%-18.49K | -673.14%-781.5K | -300.04%-379.86K | 89.60%-28.34K | -118.90%-91.22K | -1,430.18%-282.08K | 2,511.62%136.35K | ---94.96K |
| -Change in other current liabilities | -961.50%-56.48K | ---55.35K | ---54.74K | --244.51K | --237.95K | --6.56K | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -10.79%-1.16M | 6.38%-1.21M | 25.23%-1.23M | -11.42%-5.67M | 45.98%-1.69M | 24.84%-1.04M | -227.49%-1.29M | -786.17%-1.65M | -769.82%-5.09M | ---3.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 9.77%-78.57K | -129.53%-201.07K | -32.78%-69.94K | -115.84%-794.29K | -22,469.59%-566.95K | 73.36%-87.07K | -295.12%-87.6K | -220.48%-52.67K | -1.09%-368K | -2.51K |
| Net PPE purchase and sale | 31.51%-23.25K | -545.28%-167.9K | ---19.99K | ---575.66K | ---515.7K | ---33.94K | ---26.02K | --0 | --0 | --0 |
| Net intangibles purchase and sale | -4.13%-55.32K | 46.13%-33.17K | 5.16%-49.96K | -159.05%-197.28K | -357.60%-29.9K | -71.29%-53.13K | -177.76%-61.58K | -220.48%-52.67K | 33.22%-76.15K | ---6.53K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 156.59%141.49K | --4.02K |
| Net other investing changes | ---- | ---- | ---- | 95.07%-21.35K | ---- | ---- | ---- | ---- | ---433.33K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 9.77%-78.57K | -129.53%-201.07K | -32.78%-69.94K | -115.84%-794.29K | -22,469.59%-566.95K | 73.36%-87.07K | -295.12%-87.6K | -220.48%-52.67K | -1.09%-368K | ---2.51K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 774.32%1.91M | 509.33%1.16M | -63.13%1.58M | -59.92%3.63M | 94.58%-93.5K | -127.73%-283.01K | -102.90%-283.01K | 4.29M | 639.90%9.06M | -1.72M |
| Net issuance payments of debt | --0 | --0 | --0 | --4.5M | --0 | --0 | --0 | --4.5M | --0 | --0 |
| Net common stock issuance | --2M | --1.3M | --1.88M | --0 | --0 | --0 | --0 | --0 | 970.18%11.99M | ---1 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --390K | --0 | --0 | --0 | --390K | --0 | --0 |
| Net other financing activities | 66.96%-93.5K | 50.44%-140.25K | 50.63%-295.25K | 56.97%-1.26M | 94.58%-93.5K | -176.66%-283.01K | ---283.01K | ---598.01K | -2,883.16%-2.92M | ---1.72M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 774.32%1.91M | 509.33%1.16M | -63.13%1.58M | -59.92%3.63M | 94.58%-93.5K | -127.73%-283.01K | -102.90%-283.01K | --4.29M | 639.90%9.06M | ---1.72M |
| Net cash flow | ||||||||||
| Beginning cash position | -74.03%1.31M | -76.70%1.56M | -68.83%1.28M | 703.00%4.12M | -59.51%3.63M | -47.78%5.04M | 2,062.12%6.71M | 703.00%4.12M | 116.28%512.77K | --8.96M |
| Current changes in cash | 147.54%672.47K | 84.79%-253.02K | -89.21%279.62K | -178.62%-2.83M | 51.59%-2.35M | -103.25%-1.41M | -117.79%-1.66M | 1,378.97%2.59M | 1,207.59%3.6M | ---4.85M |
| End cash Position | -45.38%1.98M | -74.03%1.31M | -76.70%1.56M | -68.83%1.28M | -68.83%1.28M | -59.51%3.63M | -47.78%5.04M | 2,062.12%6.71M | 703.00%4.12M | --4.12M |
| Free cash flow | -9.21%-1.24M | -2.25%-1.41M | 23.43%-1.3M | -24.73%-6.45M | 28.64%-2.23M | 20.35%-1.13M | -231.08%-1.38M | -740.26%-1.7M | -638.88%-5.17M | ---3.13M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data